Drugs & Targets CHMP recommends approval for Tevimbra as a first-line treatment for extensive-stage small cell lung cancer April 04, 2025Vol.51 No.13
Drugs & Targets Exact Sciences launches the Cologuard Plus test for colorectal cancer screening April 04, 2025Vol.51 No.13
Capitol Hill Kennedy announces massive cuts, centralization at HHS—NCI and FDA hitAlso this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology March 28, 2025Vol.51 No.12By Claire Marie Porter and Jacquelyn Cobb
News Analysis DOD cancer research programs face 57% funding cut in year-long continuing resolutionPancreatic, lung, kidney cancer research programs eliminated March 28, 2025Vol.51 No.12By Jacquelyn Cobb
Guest Editorial Rathmell: We must support our junior colleagues“Empathy and listening is a key place to start” March 28, 2025Vol.51 No.12By W. Kimryn Rathmell
Guest Editorial Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunityWeill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration March 28, 2025Vol.51 No.12By Jedd D. Wolchok, Joshua D. Rabinowitz and Sohail Tavazoie
In Brief Weill Cancer Hub East established to investigate interplay between nutrition, metabolism, and immunotherapy March 28, 2025Vol.51 No.12
In Brief Keith Flaherty to become president-elect of AACR for 2025-2026, Michael Caligiuri named treasurer March 28, 2025Vol.51 No.12
In Brief Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application March 28, 2025Vol.51 No.12
